Tetrabenazine
- 25 November 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 10 (17) , 2883-2896
Abstract
(2009). Tetrabenazine. Expert Opinion on Pharmacotherapy: Vol. 10, No. 17, pp. 2883-2896. doi: 10.1517/14656560903386292Keywords
This publication has 76 references indexed in Scilit:
- Dopaminergic Signaling and Striatal Neurodegeneration in Huntington's DiseaseThe Journal of Neuroscience, 2007
- Short‐term effects of tetrabenazine on chorea associated with Huntington's diseaseMovement Disorders, 2007
- Is History of Depression a Contraindication to Treatment With Tetrabenazine?Clinical Neuropharmacology, 2006
- Tetrabenazine in the treatment of severe pediatric choreaMovement Disorders, 2003
- Nithsdale Schizophrenia Surveys 23: movement disordersThe British Journal of Psychiatry, 2002
- Repetitive administration of tetrabenazine induces irreversible changes in locomotion and morphology of the substantia nigrain ratsExperimental and Toxicologic Pathology, 2001
- Tardive tremorMovement Disorders, 1992
- Depletion of monoamine transmitters by tetrabenazine in brain tissue in Huntington's diseaseNeuropharmacology, 1988
- Treatment of hyperkinetic movement disorders with tetrabenazine: A double‐blind crossover studyAnnals of Neurology, 1982
- A Double Blind Trial of Lithium Carbonate and Haloperidol in Huntington's ChoreaAustralian & New Zealand Journal of Psychiatry, 1975